BioCentury
ARTICLE | Clinical News

Staccato alprazolam: Phase IIa started

February 9, 2015 8:00 AM UTC

Alexza began a double-blind, placebo-controlled, crossover, U.S. Phase IIa trial to evaluate a single dose of 0.5, 1 and 2 mg inhaled Staccato in about 6 patients. ...